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after hematopoeitc cell transplantation (HCT) is critical for
the control of post-transplant infections, establishment of
graft tolerance and, in some cases, mediation of graft-versus
leukemia effects. Natural Killer (NK) cells, being the ﬁrst in
line of defense against tumors and infections, are also the
earliest among lymphocyte populations to reconstitute and
achieve functional maturity after transplantation. However,
many HCT recipients with normal recovery of NK cells
continue to suffer from complications including infections
and disease relapse suggesting that different NK cell subsets
may be responsible for anti-leukemic or anti-viral immune
response. Here, we set out to determine in healthy individ-
uals, whether different NK cell subsets (cytolytic or regula-
tory) elicit unique immune responses against different
targets (leukemia cells or herpes viruses).
Methods: Peripheral Blood Mononuclear Cells (PBMNCs)
from 25 healthy donors were stimulated with different
targets including a leukemic cell line (K562) and herpesviral
(Epstein - Barr virus, EBV) infected cell lysate. A 5-colour ﬂow
cytometry based estimation of cytotoxicity (expression of
CD107a, a surrogate marker for degranulation) and cytokine
(IFN-g) production was performed for both CD56brightCD16-
neg regulatory and CD56dimCD16pos cytolytic NK cell subsets.
Results: Different NK cell subsets were immunodominant
against different targets. Leukemia (K562) e speciﬁc response
includes both degranuation and IFN-g productionmediated by
the cytolytic and regulatory NK cell subsets. On the contrary,
EBV speciﬁc NK cell response was primarily characterized by
degranulation and was dominated by cytolytic NK cells. A
consistent shedding of CD16 was found associated with
degranulationof cytolyticNKcells in response to EBVbut not to
K562cells. CytolyticNKcells in general exhibited abifunctional
immune response against both targets while regulatory NK
cells were primarily IFN-g producers.
Conclusions: NK cell subsets elicit a unique immune
response against different targets (leukemia cells or
herpesviruses). Assessment of posttransplant recovery of
these target speciﬁc functional NK cell subsets will be more
relevant for the prediction of transplant outcomes and may
have future implications for the cellular therapy/prophylaxis
of herpesviral disease or leukemia relapse.180
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Allogeneic hematopoietic stem cell transplantation
(SCT) is the best treatment for numerous types of hema-
tological malignancies. However, graft-versus-host disease
(GVHD) is the major cause of morbidity and mortality and
its effect on T cell regeneration greatly exacerbates the
immunodeﬁciency normally associated with this treatment.
As a result, patients with GVHD are profoundly lympho-
penic and T cell reconstitution typically takes several
months or years.
We previously reported that IL7Ra-/- mice have a peri-
pheral lymphoid niche that is highly permissive for homeo-
static proliferation (HP) of CD4+ T cells. Given that CD4+ T
cells regeneration is impaired during GVHD, we hypothe-
sized that using IL7Ra-/- bone marrow (BM) might improve
their recovery in GVHD hosts. To study the impact of GVHD
on the peripheral niche regulating CD4 HP, we used themouse model B6 into B6D2F1. Since IL7Ra-/- DCs support
efﬁciently HP of naïve CD4+ T cells during lymphopenia, we
used BM stem cells from B6IL7Ra-/- mice and induced GVHD
by adding 1x106 B6 T cells. Finally, to understand the impact
of GVHD on HP, we transferred CFSE labelled anti-HY CD4+ T
cells (Marilyn) into GVHD hosts and measured their
homeostatic proliferation 7 days later.
In non GVHD hosts, Marilyn T cells underwent robust HP
while they completely failed in GVHD hosts. Absence of HP
during GVHD was associated with a severe depletion of all
DC subsets, including myeloid, lymphoid and pDCs. Low
number of DCs during GVHD was in part due to their elimi-
nation by GVHD T cells but most importantly to a myelo-
suppression affecting DC production from BM progenitor
cells. Interestingly, treatment of GVHDmice with FLT3 ligand
(FL) signiﬁcantly increased the number of DCs, yet it was
insufﬁcient for restoring CD4 HP. Given that stromal cells and
IL7 mRNA levels were also diminished in GVHD hosts, we
provided both FL and IL-7 to GVHD mice and signiﬁcantly
restored HP of Marilyn CD4+ T cells in this setting.
Thus far, our data support a model wherein loss of CD4 HP
during GVHD relates to lower numbers of DC and diminished
systemic IL7.181
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Background: Enhanced immune responses post autologous
HCT is known to be beneﬁcial for long term disease control in
MM. Early responses are mediated by NK cells and alternate
inhibitory/stimulatory pathways that include the cos-
timulatory molecules. This pilot study assesses the expres-
sion of NK cytolytic receptor (CD16) as well as the
stimulatory (OX-40, ICOS, 4-1BB, CD28, NKG2D) and inhibi-
tory (PD-1 and CTLA-4) molecules on NK cells after auto-HCT
in MM patients.
Methods: 22 patients with MM undergoing HCT, median age
59.6 years (36 - 71.4), were included in the study. Peripheral
blood sampleswere taken3daysprior toHCTand14,30, 60, 90,
180 days after HCT. At d180 post-HCT, 18/22 patients were
receiving lenalidomidewith d86 as median start date. NK cells
and their costimulatory molecules were evaluated by ﬂowcy-
tometry using 2 six color panels of antibodies. OnewayANOVA
Table 1
Pre-HCT d180
Partial Response or worse ( PR) 9 9
Very Good Partial Response or
better (VGPR)
10 0
Complete Remission (CR) 3 13
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applied to analyze the data using the Graphpad Software.
Results: The percent NK cell was highest (median: 20% of
total lymphocytes) at d14 (p: 0.0001) compared to pre and
post HCT levels and reached baseline at d 60. The percent NK
cell was higher in VGPR (n¼13) [median: 14.34% (6.29-
28.17) and 16.08 % (7.26-31.19)] compared to PR (n¼9)
[median: 8.17% (4.01- 17.3) and 7.34 %(5.79- 47.8)] respec-
tively at d 90 (p-0.019) and d 180 (p-0.045). The NK cells
expressing CD 16 was 12.2 times higher in patients after
receiving Lenalidomide (n¼18) (p-0.05) compared to pre-
lenalidomide time point.
Conclusion: After auto-HCT, NK cell recovery was reached at
60 days after HCT and was higher in VGPR compared to
PR group at later times. This observation could indicate
enhanced host NK cell immune response against MM.
Lenalidomide therapy increased the percent of NK/ CD 16+
cells that mediates ADCC immune response. Future clinical
trials will explore therapies that increase NK cell cytolytic
responses to MM cancer cells.182
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High-dose, post-transplantation Cy (PT/Cy) is a novel and
effective strategy for preventing graft-versus-host disease
(GVHD) after allogeneic blood or marrow transplantation
(alloBMT). We previously reported that regulatory T cells
(Tregs) are resistant to Cy in allogeneic reactions; activated
Tregs (CD4+CD45RA-Foxp3+hi) are relatively increased 30 and
60 days after PT/Cy in vivo and both naïve (CD4+CD45RA+-
Foxp3+) and activated Tregs are resistant to cytotoxicity
induced by activated Cy (mafosfamide) in mixed lymphocyte
reactions (MLR) in vitro. However, the mechanisms of Treg
resistance to Cy have not been understood. As resistance of
hematopoietic stem cells to Cy is dependent on expression of
the ALDH-1 family (retinaldehyde dehydrogenases), we
hypothesized that Tregs also might express ALDH as a poten-
tial mechanism of resistance to Cy. To examine ALDH
expression, we used Aldeﬂuor as an established and repro-
ducible ﬂow cytometric-based method. There was minimal
to no Aldeﬂuor-positivity in unstimulated Tregs. However,
after allogeneic stimulation in MLR, signiﬁcant subsets of
both naïve and activated Tregs were Aldeﬂuor-positive. These
ﬁndings were conﬁrmed by PCR which showed undetectable
mRNA transcript levels in unstimulated cells but signiﬁcant
upregulation of ALDH1A1 in naïve and activated Tregs at Days
3 and 7 of MLR. These ALDH+ cells persisted after mafosfa-
mide treatment but were not present in signiﬁcant amounts
in the presence of cyclosporine or rapamycin (activated Tregs,
P ¼ .027). ALDH expression correlated with expression of
the activation markers CD69 and CD25 and withproliferation. The clinical relevance of these ﬁndings was
conﬁrmed by showing Aldeﬂuor+CD4+ T cells in peripheral
blood retrieved from patients on Day 3 post-alloBMT at the
time of receiving PT/Cy. To dissect functional implications
of these ﬁndings, we explored pharmacological inhibition
of ALDH using diethylaminobenzaldehyde (DEAB). DEAB
treatment drastically reduced activation and proliferation
of CD4+CD25+ T cells in MLR (P ¼ .031 for both compari-
sons) and abolished Treg resistance to mafosfamide-induced
cytotoxicity (activated Tregs, P < .001). Therefore, resistance
of Tregs to Cy is dependent at least in part on ALDH
expression in allogeneic reactions. Given the role of ALDH
as the rate-limiting step in retinoic acid (RA) biosynthesis
and the crucial contributions of RA to both immune toler-
ance and CD4+ T cell function, pharmacologic manipulation
of this pathway may open a new avenue for modulating
alloreactivity after alloBMT.183
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Reconstitution of immune function in recipients of allo-
geneic hematopoietic cell transplantation is a prolonged
process that takes place over several years. Patients who
undergo transplantation at our facility are asked to return at
the one-year anniversary of their transplant for a compre-
hensive clinical and laboratory evaluation. We analyzed the
extent to which standard laboratory correlates of hemato-
logic and immune reconstitution at one year posttransplant
predict subsequent survival. Of 1273 patients with hemato-
logic malignancies who underwent their ﬁrst allogeneic
transplant between Jan. 1, 2001 and Dec. 31, 2010, and
survived at least one year, 875 returned for comprehensive
assessment at 12 +/- 2 months posttransplant and were
included in this retrospective study. Comparison of the
cohort of patients who returned for evaluation and those
who did not revealed no signiﬁcant differences save for
a larger proportion of patients (36.3 vs. 45.7%, p ¼ 0.002)
with high risk disease in the latter group. Patients were
classiﬁed by graft sources into 5 groups: matched related,
mismatched related, matched unrelated, mismatched unre-
lated, or unrelated cord blood (UCB). WBC, absolute
neutrophil, absolute lymphocyte, and platelet counts deter-
mined by automated cell counter were available for all
returning patients. Absolute CD4+, CD8+, CD19+, and CD56+
cell counts determined by ﬂow cytometry, and serum IgG
and IgA levels, were available for 405, 406, 389, 393, 866 and
732 patients, respectively. CD4+ lymphocytopenia at one-
year posttransplant was extremely common in all groups.
Reconstitution of CD19+ and CD56+ cells in the UCB group
was marginally better than in the other groups. However,
there were no signiﬁcant differences in the reconstitution of
CD4+ and CD8+ cells counts and serum IgG and IgA levels
according to graft sources. To determine whether any of the
common laboratory measures of immune reconstitution
observed at one year posttransplant were correlated with
subsequent survival, we conducted landmark analyses in
